| 000 | 01654 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515010417.0 | ||
| 264 | 0 | _c20060104 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0070-217X | ||
| 024 | 7 |
_a10.1007/3-540-29933-5_7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChiorazzi, N | |
| 245 | 0 | 0 |
_aClinical and laboratory parameters that define clinically relevant B-CLL subgroups. _h[electronic resource] |
| 260 |
_bCurrent topics in microbiology and immunology _c2005 |
||
| 300 |
_a109-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Variable Region _xgenetics |
| 650 | 0 | 4 | _aImmunologic Memory |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xclassification |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-bcl-6 |
| 650 | 0 | 4 |
_aReceptors, Antigen, B-Cell _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTelomere _xenzymology |
| 650 | 0 | 4 |
_aZAP-70 Protein-Tyrosine Kinase _xgenetics |
| 700 | 1 | _aAllen, S L | |
| 700 | 1 | _aFerrarini, M | |
| 773 | 0 |
_tCurrent topics in microbiology and immunology _gvol. 294 _gp. 109-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/3-540-29933-5_7 _zAvailable from publisher's website |
| 999 |
_c15950808 _d15950808 |
||